ACACIA RESEARCH CORP (ACTG) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
ACTG currently has 96.5M outstanding shares. with significant dilution risk as 102M authorized shares could dilute existing holders by 105.2%. The company has minimally diluted shareholders by 0.49% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 96.5M shares outstanding |
96M | 100M |
| Nov 06, 2025 |
10-Q filing | 96.4M shares outstanding |
96M | 100M |
| May 09, 2025 |
10-Q filing | 96.0M shares outstanding |
96M | 100M |
| Mar 17, 2025 |
10-K filing | 99.2M shares outstanding |
99M | 99M |
| Nov 12, 2024 |
10-Q filing | 99.9M shares outstanding |
100M | 98M |
| Aug 08, 2024 |
10-Q filing | 100.1M shares outstanding |
100M | 98M |
| May 10, 2024 |
10-Q filing | 99.7M shares outstanding |
100M | 98M |
| Mar 15, 2024 |
10-K filing | 92.4M shares outstanding |
92M | 110M |
| Mar 14, 2024 |
8-K filing: Acacia Research Corporation's Board approved a stock repurchase program on November 9, 2023, authorizing the company to purchase up to $20 million of its common stock, capped at 5,800,000 shares. ($20.0M proceeds) |
100M | 98M |
| Nov 13, 2023 |
10-Q filing | 99.1M shares outstanding |
99M | 99M |
| Nov 13, 2023 |
8-K filing: Acacia Research Corporation's Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $20 million of its common stock, capped at 5,800,000 shares. ($20.0M proceeds) |
100M | 98M |
| Aug 03, 2023 |
10-Q filing | 99.9M shares outstanding |
100M | 98M |
| Aug 01, 2023 |
8-K filing: Acacia Research Corporation amended its bylaws on July 27, 2023, to permit a majority of independent directors to appoint a Lead Independent Director and updated procedures for stockholder proposals. Additionally, 350,000 shares of Series A Convertible Preferred Stock were converted into common stock and subsequently retired, reducing the total number of authorized shares of Series A Convertible Preferred Stock. |
100M | 98M |
| Jul 17, 2023 |
8-K filing: Starboard converted 350,000 shares of Series A Convertible Preferred Stock into 9,616,746 shares of Common Stock and exercised 31,506,849 Series B Warrants for 31,506,849 shares of Common Stock, cancelling $60 million of senior secured notes and receiving $55 million in gross proceeds. ($55.0M proceeds) |
100M | 98M |
| May 11, 2023 |
10-Q filing | 58.6M shares outstanding |
59M | 140M |
| Mar 17, 2023 |
10-K filing | 58.6M shares outstanding |
59M | 140M |
| Mar 06, 2023 |
8-K filing: The company completed a rights offering and concurrent private rights offering, resulting in the issuance of 68,753 shares and 15,000,000 shares of Common Stock, respectively, with Starboard Value LP participating in the private rights offering and becoming a significant shareholder. ($79.11M proceeds) |
59M | 140M |
| Nov 14, 2022 |
10-Q filing | 43.5M shares outstanding |
44M | 150M |
| Nov 01, 2022 |
8-K filing: Acacia Research Corporation entered into a Recapitalization Agreement with Starboard Value LP to restructure Starboard's investments in the Company, involving preferred stock conversion, warrant exercises, a rights offering, and a recapitalization payment. |
38M | 160M |
| Sep 30, 2022 |
8-K filing: Acacia Research Corporation amended the Series B Warrants to further extend the Cash Exercise Date from September 30, 2022 to October 28, 2022 to allow for additional time to reach a resolution with Starboard Value LP. |
38M | 160M |
| Sep 15, 2022 |
8-K filing: Acacia Research Corporation amended the Series B Warrants for a second time to extend the Cash Exercise Date from September 15, 2022, to September 30, 2022, to allow for additional time to reach a resolution with Starboard. |
38M | 160M |
| Aug 24, 2022 |
8-K filing: Acacia Research Corporation amended Series B Warrants to extend the Cash Exercise Date to September 15, 2022, allowing for potential resolution with Starboard Value LP and permitting cash payment for the lower exercise price of $3.65 for 31,506,849 warrants. |
38M | 160M |
| Aug 11, 2022 |
10-Q filing | 38.3M shares outstanding |
38M | 160M |
| May 12, 2022 |
10-Q filing | 46.5M shares outstanding |
47M | 150M |
| Mar 31, 2022 |
10-K filing | 48.8M shares outstanding |
49M | 150M |
| Nov 15, 2021 |
10-Q filing | 48.9M shares outstanding |
49M | 150M |
| Aug 16, 2021 |
10-Q filing | 48.7M shares outstanding |
49M | 150M |
| May 17, 2021 |
10-Q filing | 48.6M shares outstanding |
49M | 150M |
| Apr 06, 2021 |
8-K filing: Acacia Research Corporation, through its subsidiary Merton Acquisition HoldCo LLC, issued an additional $50 million in senior secured notes to Starboard Value LP on March 31, 2021, as part of a Second Supplemental Agreement, bringing the total outstanding amount of Merton Notes to $115 million. |
49M | 150M |
| Mar 29, 2021 |
10-K filing | 48.8M shares outstanding |
49M | 150M |
| Nov 19, 2020 |
S-3/A filing: Acacia Research Corporation files an S-3/A form for a shelf offering of common stock, preferred stock, and debt securities, with a total proposed amount of $100,000,000, and registers 148,965,762 shares of common stock offered by selling stockholders. |
49M | 150M |
| Nov 09, 2020 |
10-Q filing | 48.5M shares outstanding |
48M | 150M |
| Nov 09, 2020 |
S-3 filing: Acacia Research Corporation is filing an S-3 to offer common stock, preferred stock and debt securities with an aggregate initial offering price not to exceed $100,000,000. Also, selling stockholders may offer and sell up to an aggregate of 148,965,762 shares of common stock. |
49M | 150M |
| Aug 10, 2020 |
10-Q filing | 49.0M shares outstanding |
49M | 0 |
| Jul 20, 2020 |
8-K filing: Acacia Research Corporation entered into a Securities Purchase Agreement with Starboard Value LP for the issuance of preferred shares and warrants. |
49M | 0 |
| Jun 10, 2020 |
8-K filing: Acacia Research Corporation entered into a Transaction Agreement with LF Equity Income Fund to acquire a portfolio of securities of 19 public and private life sciences companies for £223.9 million, and issued $115 million principal amount of Senior Secured Notes to Starboard in connection with the Portfolio Transaction. |
49M | 0 |
| May 11, 2020 |
10-Q filing | 48.7M shares outstanding |
49M | 0 |
| Mar 16, 2020 |
10-K filing | 50.9M shares outstanding |
51M | 0 |